New Leaf Venture Partners, L.L.C. Arvinas, Inc. Transaction History
New Leaf Venture Partners, L.L.C.
- $96.9 Million
- Q3 2024
A detailed history of New Leaf Venture Partners, L.L.C. transactions in Arvinas, Inc. stock. As of the latest transaction made, New Leaf Venture Partners, L.L.C. holds 1,434,721 shares of ARVN stock, worth $32.6 Million. This represents 36.46% of its overall portfolio holdings.
Number of Shares
1,434,721
Previous 1,289,521
11.26%
Holding current value
$32.6 Million
Previous $34.3 Million
2.94%
% of portfolio
36.46%
Previous 41.81%
Shares
5 transactions
Others Institutions Holding ARVN
# of Institutions
229Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$159 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$153 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$142 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$87.4 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$63.1 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.21B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...